Who can use Fasturtec(Rasburicase)?

The specific medical conditions and patient populations for which the drug is approved.

Approved Uses

Elitek is indicated for the initial management of plasma uric acid levels in pediatric and adult patients with leukemia, lymphoma, and solid tumor malignancies who are receiving anticancer therapy expected to result in tumor lysis and subsequent elevation of plasma uric acid. Its use is restricted to a single treatment course only and is not approved for repeated dosing regimens.